Unicycive Therapeutics (UNCY) Earnings Date, Estimates & Call Transcripts $0.46 +0.01 (+2.22%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Unicycive Therapeutics Latest Earnings SummaryLatest Q2 2024 Earnings DateAug. 14EstimatedActual EPS (Aug. 14) -$0.15 Beat By $0.08 Consensus EPS (Aug. 14) -$0.23 Unicycive Therapeutics issued Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.15, which topped the consensus estimate of -$0.23 by $0.08. With a trailing EPS of -$0.97, Unicycive Therapeutics' earnings are expected to grow next year, from ($0.23) to ($0.08) per share. Get Unicycive Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Unicycive Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUNCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UNCY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Unicycive Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.18-$0.18-$0.18Q2 20242-$0.25-$0.21-$0.23Q3 20243-$0.28-$0.07-$0.14Q4 20243-$0.30-$0.07-$0.15FY 20249-$1.01-$0.53-$0.70Q1 20252-$0.30-$0.07-$0.19Q2 20252-$0.31-$0.08-$0.20Q3 20252-$0.10$0.27$0.09Q4 20252-$0.08$0.36$0.14FY 20258($0.79)$0.48($0.16) Unicycive Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/14/2024Q2 2024-$0.23-$0.15+$0.08-$0.15--5/13/2024Q1 2024-$0.18-$0.27 -$0.09$0.07--3/28/2024Q4 2023-$0.18-$0.16+$0.02-$0.16--11/14/2023Q3 2023-$0.13-$0.13--$0.13--8/14/2023Q2 2023-$0.39-$0.29+$0.10-$0.29--5/16/2023Q1 2023-$0.36-$0.29+$0.07$0.39$0.75M$0.68M Get the Latest News and Ratings for UNCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Unicycive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/31/2023Q4 2022--$0.35 -$0.35-$0.35-- Unicycive Therapeutics Earnings - Frequently Asked Questions When did Unicycive Therapeutics announce their last quarterly earnings? Unicycive Therapeutics (NASDAQ:UNCY) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on UNCY's earnings history. Did Unicycive Therapeutics beat their earnings estimates last quarter? In the previous quarter, Unicycive Therapeutics (NASDAQ:UNCY) reported ($0.15) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.08. Learn more on analysts' earnings estimate vs. UNCY's actual earnings. How much revenue does Unicycive Therapeutics generate each year? Unicycive Therapeutics (NASDAQ:UNCY) has a recorded annual revenue of $680,000.00. How much profit does Unicycive Therapeutics generate each year? Unicycive Therapeutics (NASDAQ:UNCY) has a recorded net income of -$30.54 million. UNCY has generated -$0.97 earnings per share over the last four quarters. What is Unicycive Therapeutics's EPS forecast for next year? Unicycive Therapeutics's earnings are expected to grow from ($0.23) per share to ($0.08) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Black Diamond Therapeutics Earnings Date Atai Life Sciences Earnings Date LifeVantage Earnings Date Acumen Pharmaceuticals Earnings Date Sagimet Biosciences Earnings Date Atossa Therapeutics Earnings Date Instil Bio Earnings Date Actuate Therapeutics Earnings Date Cardiff Oncology Earnings Date Tenaya Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for Investors Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> This page (NASDAQ:UNCY) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Unicycive Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
